🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III trial studies how well pembrolizumab works in treating patie...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-03
Trial ID
NCT03244384
This phase II trial studies the effect of rogaratinib in treating patients ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-05-03
Trial ID
NCT04595747
This early phase I pilot trial studies how well 64Cu-DOTA-alendronate posit...
Status
Completed
Location
City of Hope Medical Center
Start Date
2021-11-03
Trial ID
NCT03542695
Radiotherapy (combined with chemotherapy) is commonly used in the curative ...
Status
Completed
Location
University Medical Center Groningen
Start Date
2016-12
Trial ID
NCT03022539
Treatments Being Tested
The primary objective of this study is to determine the effectiveness of th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT04466553
Treatments Being Tested
The aim of the study is to compare aesthetic results and operation time of ...
Status
Unknown
Location
Faculity of Dentistry-Cairo university
Start Date
2019-07
Trial ID
NCT03757286
Treatments Being Tested
This pilot phase II trial studies how well pembrolizumab works in treating ...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2017-02-06
Trial ID
NCT02775851
This phase Ib trial tests the safety and effectiveness of epcoritamab in tr...
Status
Recruiting
Location
Washington University
Start Date
2025-06-16
Trial ID
NCT06672705
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of TR-002 f...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2025-11-07
Trial ID
NCT07189195
Treatments Being Tested
This phase I/Ia trial finds the best dose and side effects of venetoclax gi...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-08-03
Trial ID
NCT04847453